• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I Back to Search Results
Catalog Number 02K41-27
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/15/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.An evaluation is in process.
 
Event Description
The customer observed multiple false positive cardiac troponin-i while using architect stat troponin-i reagents.The following data was provided for the same patient.The customer uses normal range less than 0.06 ng/ml, abnormal range 0.06 to 0.19 ng/ml, and elevated greater than or equal to 0.2 ng/ml.Patient 1: sid (b)(4) ((b)(4) collected march 25, 2018 13:33) initial 0.213 ng/ml (positive), repeat 0.056 (negative), 0.198 (positive), 0.008, 0.00 ng/ml (negative).Sid 18-084-02206 (previous specimen, initial tested march 25, 2018) initial 0.02 ng/ml (negative), repeat 0.11 ng/ml (positive), 0.00 ng/ml (negative).Sid (b)(4) (initial tested march 25, 2018) initial less than 0.03 ng/ml (negative), repeat 0.000 ng/ml (negative).Patient 2: sid (b)(4) (collection and test date not provided) initial 0.213 ng/ml (positive), repeat 0.56 ng/ml (negative), 0.198 ng/ml (positive), 0.008 ng/ml (negative).No adverse impact to patient management was reported.
 
Manufacturer Narrative
Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, device history review, instrument log review, labeling review, and field data review.No adverse trend was identified for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Log review did not identify any issues that contributed to the customer issue.Labeling was reviewed and found to be adequate.Review of field data showed the complaint lot patient median value was within established control limits and no unusual reagent performance was identified.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT STAT TROPONIN-I
Type of Device
TROPONIN-I
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key7403939
MDR Text Key105251006
Report Number1415939-2018-00073
Device Sequence Number1
Product Code MMI
UDI-Device Identifier00380740048525
UDI-Public00380740048525
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K041192
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/06/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Catalogue Number02K41-27
Device Lot Number28393UN17
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/02/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-